127 related articles for article (PubMed ID: 33126125)
21. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody.
Oliai BR; Kahane H; Epstein JI
Am J Surg Pathol; 2002 Sep; 26(9):1151-60. PubMed ID: 12218571
[TBL] [Abstract][Full Text] [Related]
22. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
[TBL] [Abstract][Full Text] [Related]
23. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
[TBL] [Abstract][Full Text] [Related]
24. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
25. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
26. Automatic grading of prostate cancer in digitized histopathology images: Learning from multiple experts.
Nir G; Hor S; Karimi D; Fazli L; Skinnider BF; Tavassoli P; Turbin D; Villamil CF; Wang G; Wilson RS; Iczkowski KA; Lucia MS; Black PC; Abolmaesumi P; Goldenberg SL; Salcudean SE
Med Image Anal; 2018 Dec; 50():167-180. PubMed ID: 30340027
[TBL] [Abstract][Full Text] [Related]
27. Machine learning approaches to analyze histological images of tissues from radical prostatectomies.
Gertych A; Ing N; Ma Z; Fuchs TJ; Salman S; Mohanty S; Bhele S; Velásquez-Vacca A; Amin MB; Knudsen BS
Comput Med Imaging Graph; 2015 Dec; 46 Pt 2(Pt 2):197-208. PubMed ID: 26362074
[TBL] [Abstract][Full Text] [Related]
28. Additional elastography-targeted biopsy improves the agreement between biopsy Gleason grade and Gleason grade at radical prostatectomy.
Boehm K; Tennstedt P; Beyer B; Schiffmann J; Beckmann A; Michl U; Beyersdorff D; Budäus L; Graefen M; Karakiewicz PI; Salomon G
World J Urol; 2016 Jun; 34(6):805-10. PubMed ID: 26481227
[TBL] [Abstract][Full Text] [Related]
29. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
[TBL] [Abstract][Full Text] [Related]
30. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
[TBL] [Abstract][Full Text] [Related]
31. Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E- and IHC-stained histopathological specimens.
Leng E; Henriksen JC; Rizzardi AE; Jin J; Nam JW; Brassuer BM; Johnson AD; Reder NP; Koopmeiners JS; Schmechel SC; Metzger GJ
Sci Rep; 2019 May; 9(1):6992. PubMed ID: 31061447
[TBL] [Abstract][Full Text] [Related]
32. [Clinical value of serum isoform [-2] proprostate-specific antigen and its derivatives in predicting aggressive prostate cancer].
Sun KX; Yan CL; Li ZY; Liu P; Zhang W; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Apr; 52(2):234-239. PubMed ID: 32306004
[TBL] [Abstract][Full Text] [Related]
33. Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillance.
Bokhorst LP; Roobol MJ; Bangma CH; van Leenders GJ
Prostate; 2017 Jul; 77(10):1137-1143. PubMed ID: 28543353
[TBL] [Abstract][Full Text] [Related]
34. Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network.
Aldoj N; Lukas S; Dewey M; Penzkofer T
Eur Radiol; 2020 Feb; 30(2):1243-1253. PubMed ID: 31468158
[TBL] [Abstract][Full Text] [Related]
35. Going deeper through the Gleason scoring scale: An automatic end-to-end system for histology prostate grading and cribriform pattern detection.
Silva-Rodríguez J; Colomer A; Sales MA; Molina R; Naranjo V
Comput Methods Programs Biomed; 2020 Oct; 195():105637. PubMed ID: 32653747
[TBL] [Abstract][Full Text] [Related]
36. PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.
Carleton NM; Zhu G; Gorbounov M; Miller MC; Pienta KJ; Resar LMS; Veltri RW
Prostate; 2018 May; 78(7):547-559. PubMed ID: 29520928
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic utility of P504S/p63 cocktail, prostate-specific antigen, and prostatic acid phosphatase in verifying prostatic carcinoma involvement in seminal vesicles: a study of 57 cases of radical prostatectomy specimens of pathologic stage pT3b.
Harvey AM; Grice B; Hamilton C; Truong LD; Ro JY; Ayala AG; Zhai QJ
Arch Pathol Lab Med; 2010 Jul; 134(7):983-8. PubMed ID: 20586625
[TBL] [Abstract][Full Text] [Related]
38. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI
Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803
[TBL] [Abstract][Full Text] [Related]
39. Expression of CDX2 in benign tissue and adenocarcinoma of the prostate.
Herawi M; De Marzo AM; Kristiansen G; Epstein JI
Hum Pathol; 2007 Jan; 38(1):72-8. PubMed ID: 16949907
[TBL] [Abstract][Full Text] [Related]
40. Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential.
Waingankar N; Martini A; Griffiths L; Shah P; Paulucci DJ; Kotamarti S; Gul Z; Elmasri M; Yaskiv O; Haines K; Lerner S; Vira M; Kavoussi LR; Tewari AK; Kapoor DA; Olsson CA
Urol Oncol; 2020 Mar; 38(3):78.e15-78.e21. PubMed ID: 31796374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
